Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-28

Clinical Trial Update: 5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities [Phase 2]

View source ↗

Summary

Phase 2 trial update for a 5-ALA Patch-PDT treatment targeting actinic keratoses on the upper extremities; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-ALA Patch-PDT (5-aminolevulinic acid patch photodynamic therapy)

Snippet

Sponsor: photonamic GmbH & Co. KG | Conditions: Actinic Keratoses | Phase 2 | Status: COMPLETED